Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies

Abstract

The results provide for the first time an estimate of the prevalence of SMA at the national level and the current distribution of patients treated with the available therapeutical options. These data provide a baseline to assess future changes in relation to the evolving therapeutical scenario.